Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Sell
12
DRMA Quote, Financials, Valuation and Earnings
Last price:
$2.16
Seasonality move
:
-34.61%
Day range:
$2.25 - $2.42
52-week range:
$2.21 - $23.70
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.60x
Volume:
66.3K
Avg. volume:
158.5K
1-year change:
-79.09%
Market cap:
$2.4M
Revenue:
--
EPS (TTM):
-$16.27
Earnings Data
Next earnings date for DRMA
--
Most recent earnings per share
-$1.65
Missed by $1.65
(Sep 30/2025)
Consensus Estimate
--
(Sep 30/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
DRMA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 12/31/2025 | Q4 | -- | -- | -- | -- | -- |
| 09/30/2025 | Q3 | -- | -- | -$1.65 | -- | -- |
| 06/30/2025 | Q2 | -- | -- | -$1.66 | -- | -- |
| 03/31/2025 | Q1 | -- | -- | -$0.45 | -- | -- |
| 12/31/2024 | Q4 | -- | -- | -$12.51 | -- | -- |
| 09/30/2024 | Q3 | -- | -- | -$2.04 | -- | -- |
| 06/30/2024 | Q2 | -- | -- | -$4.18 | -- | -- |
| 03/31/2024 | Q1 | -- | -- | -$7.06 | -- | -- |
| 12/31/2023 | Q4 | -- | -- | -$8.14 | -- | -- |
| 09/30/2023 | Q3 | -- | -- | -$8.09 | -- | -- |
| 06/30/2023 | Q2 | -- | -- | -$9.43 | -- | -- |
| 03/31/2023 | Q1 | -- | -- | -$34.08 | -- | -- |
| 12/31/2022 | Q4 | -- | -- | -$32.52 | -- | -- |
| 09/30/2022 | Q3 | -- | -- | -$47.40 | -- | -- |
| 09/27/2022 | Q2 | -- | -- | -$58.54 | -- | -- |
| 05/31/2022 | Q1 | -- | -- | -$80.06 | -- | -- |
| 02/28/2022 | Q4 | -- | -- | -$73.56 | -- | -- |
| 11/15/2021 | Q3 | -- | -- | -$123.19 | -- | -- |
| 09/27/2021 | Q2 | -- | -- | -$38.38 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$66.42 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$114.21 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$17.22 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$23.68 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$40.95 | -- | -- |
Dermata Therapeutics, Inc. Earnings Questions
-
How Much did Dermata Therapeutics, Inc. Generate in Revenue Last Quarter?
Dermata Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Dermata Therapeutics, Inc. Beat Earnings Last Quarter?
Dermata Therapeutics, Inc. announced earnings per share of -$1.65 which represents a miss of analyst forecast a -- per share.
-
Is Dermata Therapeutics, Inc. Profitable?
Dermata Therapeutics, Inc. reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Dermata Therapeutics, Inc. EPS Next Year?
Dermata Therapeutics, Inc.'s earnings are forecast to grow from -$80.32 per share to -- per share next year representing an increase of --.
-
When is Dermata Therapeutics, Inc.'s Earnings Date?
Currently, Dermata Therapeutics, Inc. has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on March 20, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Sell
46
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
67
Is GOOG Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 37x
Alerts
Sell
46
BE alert for Dec 18
Bloom Energy Corp. [BE] is up 4.27% over the past day.
Sell
44
STRL alert for Dec 18
Sterling Infrastructure, Inc. [STRL] is up 6.62% over the past day.
Sell
39
SOXL alert for Dec 18
Direxion Daily Semiconductor Bull 3X Shares [SOXL] is up 7.28% over the past day.
